Hypofractionated RT for Breast Cancer Post-Mastectomy as Effective as Standard RT Randomized trial a "game changer" for patients who have implant-based reconstruction, expert says Oct 04, 2023
SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancer Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks Oct 03, 2023
Sexual Activity Lowers Risk of Side Effects After Cervical Cancer Treatment Intercourse and/or vaginal dilation reduces risk of vaginal stenosis Oct 03, 2023
SABR Offers New Hope for Older Patients With Inoperable Kidney Cancer Phase II study shows 100% local control and cancer-specific survival after more than 3 years Oct 01, 2023
SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancer Combination improved biochemical response and PFS compared with systemic treatment alone Sep 27, 2023
Individualized SABR for Lung Tumors Yields Low Recurrence Rates Strategy also results in low rates of severe toxic effects Sep 14, 2023
IMRT Best for Locally Advanced NSCLC, Study Suggests Technique reduces risk of severe lung toxicity and radiation to the heart compared with 3D-CRT Sep 13, 2023
MR-Guided Adaptive SBRT Tied to Reduced Side Effects in Prostate Cancer However, this technique requires more time and resources than standard techniques Jul 24, 2023
Immunotherapy Added to SABR Improves Event-Free Survival in Early NSCLC Approach is "potentially practice-changing," editorialist says Jul 20, 2023
Oral Cancer Patients Face Worse Outcomes With Delayed Radiation Therapy Failure to initiate adjuvant radiation therapy within 6 weeks tied to survival rates Jul 10, 2023
Primary Surgery vs Radiation in Oropharyngeal Cancer: Does One Come Out a Winner? Higher short-term dysphagia risk with surgery, but RT/CRT had worse 5-year OS Jul 09, 2023
IMRT Dosing Strategy Eases Dysphagia in Head and Neck Cancer A new standard for patients receiving intensity-modulated radiotherapy for pharyngeal cancers? Jul 07, 2023
Skipping Radiotherapy 'Seems Safe' for PMBCL Patients in Remission PET-negative patients after chemoimmunotherapy fared well with observation alone Jun 07, 2023
Omitting RT Safe in Many Locally Advanced Rectal Cancers Most intermediate-risk cases can be cured without pelvic radiation, says investigator Jun 05, 2023
Adaptive RT Fails to Relieve Dry Mouth in Head and Neck Cancer "Expensive and intensive" process does not translate into clinical benefit, researchers conclude Jun 01, 2023
Dual-Chamber Leadless Pacemaker Impresses in Safety-and-Performance Study Device provided atrial pacing, reliable atrioventricular synchrony for 3 months post-implantation May 21, 2023
PCI 'Roadmap' for the Coronary Tree Cuts Contrast Use Tool could hold promise for reducing acute kidney injury risk May 19, 2023
ChatGPT Passes Board Exam Here's how two versions of the chatbot performed on mock radiology boards May 16, 2023
Implanted Ultrasound Device Opening Blood-Brain Barrier Promising in Brain Tumors Device allows delivery of more potent chemotherapies to patients with glioblastomas May 03, 2023
Robust PSA Drops With Radionuclide Therapy in Castration-Resistant Prostate Cancer All but one patient had a PSA decline after a fractionated dose of 225Ac-J591 Apr 18, 2023
Pulsed Field Afib Ablation Hits Endpoints in Pivotal Trial Technology appears durable in most patients Mar 08, 2023
'Our Goal Is Not to Omit Radiation Therapy' in Breast Cancer Honing indications for de-escalation of treatment intensity and, yes, selective omission of RT Mar 06, 2023
Immediate Complete Revascularization Non-Inferior to Staged Procedure Patients with ACS and multivessel disease saw multiple outcome benefits in BIOVASC trial Mar 05, 2023
Safe to Omit RT After Lumpectomy in Certain Older Breast Cancer Patients Radiotherapy reduced local recurrence, but showed no effect on OS, distant recurrence Feb 15, 2023
Perioperative Chemo Matches Multimodal Tx for Locally Advanced Esophageal/GEJ Cancer Nearly identical 3-year survival, questioning the need for radiotherapy before surgery Jan 20, 2023
MRI-Guided Focused Ultrasound Eases Pain From Bone Metastases More responses with ultrasound, but quality-of-life scores lower vs EBRT in nonrandomized trial Jan 11, 2023
Genomic Assay May Pinpoint Who Can Skip RT After Breast-Conserving Surgery Patients categorized as low risk with 16-gene signature showed no significant benefit with RT Jan 06, 2023
Optimizing Treatment for Older Patients With HR+ Low-Risk Breast Cancer Five days of radiotherapy, five years of hormonal therapy, or somewhere in between? Jan 05, 2023
Metastasis-Directed Therapy May Delay ADT in Advanced Prostate Cancer Surgery or radiation delayed initiation of systemic therapy by 18 months Nov 29, 2022
RT After Breast-Conserving Surgery Shows No Survival Advantage Decades Later But "that's not the intent of radiation therapy," says outside expert Nov 18, 2022
Treatment De-Escalation Shows Promise in Testicular Cancer Early trial misses primary PFS endpoint, but "favorable" outcomes seen nonetheless Nov 03, 2022
Metastasis-Directed Therapy for Prostate Cancer Increases PFS, Time off Hormones Radiotherapy led to "dramatic" slowing of progression, increased time with normal testosterone Oct 27, 2022
Ablative MR-Guided RT Shows Promise in Pancreatic Cancer SMART safe in patients with borderline or locally advanced cancer, with encouraging early OS data Oct 27, 2022
Concurrent Boost During Hypofractionated RT Proves Its Worth in Early Breast Cancer Reduces treatment time, noninferior to conventional RT with sequential boost after lumpectomy Oct 26, 2022
Radiation for Asymptomatic Bone Metastases May Improve Cancer Survival Fewer skeletal events, less pain unexpectedly followed by longer life Oct 26, 2022
Sexual Health Not Part of Discussion for Women Undergoing Brachytherapy Much less likely than men to be queried about sexual function when receiving treatment Oct 25, 2022
Shorter Course of Radiation Therapy Proves Mettle in High-Risk Prostate Cancer Hypofractionation matches standard RT for survival and toxicity in a third less time Oct 25, 2022
New Standard-of-Care Therapy for Advanced Liver Cancer Stereotactic body radiotherapy plus sorafenib improves survival versus targeted drug alone Oct 24, 2022
Rapid Radiotherapy Technique Shows Promise in First Human Trial FLASH relieved pain in most patients with bone metastases, with few side effects Oct 24, 2022
High-Dose-Rate Brachytherapy Boost in Prostate Cancer Improves QOL Patients report better urinary and bowel function outcomes Oct 24, 2022
